Aethlon Medical, Inc.
AEMD
$1.59
$0.042.58%
NASDAQ
| 06/30/2025 | 03/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | -10.56% | 10.43% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -10.56% | 10.43% | |||
| Operating Income | 10.56% | -10.43% | |||
| Income Before Tax | 71.83% | -256.45% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 71.83% | -256.45% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 71.83% | -256.45% | |||
| EBIT | 10.56% | -10.43% | |||
| EBITDA | 10.95% | -10.93% | |||
| EPS Basic | 75.34% | -242.25% | |||
| Normalized Basic EPS | 75.34% | -242.23% | |||
| EPS Diluted | 75.34% | -242.25% | |||
| Normalized Diluted EPS | 75.34% | -242.23% | |||
| Average Basic Shares Outstanding | 14.23% | 4.15% | |||
| Average Diluted Shares Outstanding | 14.23% | 4.15% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||